Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Lebrikizumab by F. Hoffmann-La Roche for Perennial Allergic Rhinitis: Likelihood of Approval
Lebrikizumab is under clinical development by F. Hoffmann-La Roche and currently in Phase III for Perennial Allergic Rhinitis. According to...
Lebrikizumab by F. Hoffmann-La Roche for Nasal Polyps (Nasal Polyposis): Likelihood of Approval
Lebrikizumab is under clinical development by F. Hoffmann-La Roche and currently in Phase III for Nasal Polyps (Nasal Polyposis). According...
Lebrikizumab by F. Hoffmann-La Roche for Rhinosinusitis: Likelihood of Approval
Lebrikizumab is under clinical development by F. Hoffmann-La Roche and currently in Phase III for Rhinosinusitis. According to GlobalData, Phase...
Lebrikizumab by Eli Lilly and Co for Atopic Dermatitis (Atopic Eczema): Likelihood of Approval
Lebrikizumab is under clinical development by Eli Lilly and Co and currently in Pre-Registration for Atopic Dermatitis (Atopic Eczema). According...